MULTIDISCIPLINARY MASTERCLASS BLADDER AND PROSTATE CANCER

Unique input of pathology, artificial intelligence and genetics for diagnostic and theranostic purposes

JULY 8th 2022 - 14:45 - France time - Central European Summer Time (CEST)
fotos speakers (46).png
14:45 -15:00
WELCOME

Dr Gérard Friedlander


 
University of Paris Foundation, France
fotos speakers (47).png
15:00 -15:20
Dr Roland Seiler-Blarer
University Hospital Bern, Switzerland
Clinician view
fotos speakers (48).png
15:20 -15:40
Dr Eva Compérat
University of Paris, France
Histopathology: what's new?
fotos speakers (49).png
15:40 -16:00
Dr Andres Matoso
Johns Hopkins Hospital, Baltimore, USA
Immunohistochemistry: potentialities and pitfalls
fotos speakers (50).png
16:00 -16:20
Dr Mauro Saieg
Santa Casa Medical School, Sao Paulo, Brazil
Overview of Paris 2.0 reporting system
fotos speakers (54).png
16:20 -16:40
Dr Momin Siddiqui
Weill College of Medicine, New York, USA
Paris 2.0 reporting system: high grade lesions
fotos speakers (66).png
16:40 -17:00
Q&A (Questions-and-Answers) Session

Moderator:

Dr Laetitia Lacoste-Collin - Medipath, Toulouse, France
JULY 8th 2022 - 17:00 - France time - Central European Summer Time (CEST)
fotos speakers (51).png
17:00 -17:20
Dr Güliz Barkan
University of Loyola, Maywood, USA
Paris 2.0 reporting system: what is atypia
and what's not
fotos speakers (52).png
17:20 -17:40
Dr Christopher VandenBussche
Johns Hopkins Hospital, Baltimore, USA
Paris 2.0 reporting system: upper urinary tract
fotos speakers (92).png
17:40 -18:00
Dr Lukas Bubendorf
University of Basel, Switzerland
Ancillary techniques: FISH
fotos speakers (62).png
18:00 -18:20
Dr Camelia Radulescu
Foch Hospital, Suresnes, France
Artificial intelligence
fotos speakers (54).png
18:20 -18:40
Q&A (Questions-and-Answers) Session

Moderator:

Dr Momin Siddiqui - Weill College of Medicine, New York, USA
JULY 9th 2022 - 14:00 - France time - Central European Summer Time (CEST)
fotos speakers (61).png
14:00 -14:20
Dr Anna Patrikidou
Gustave Roussy Cancer Institute, Villejuif, France
Clinician view
fotos speakers (60).png
14:20 -14:40
Dr Angelo Demarzo
Johns Hopkins Hospital, Baltimore, USA
Histopathology: what's new?
fotos speakers (92).png
14:40 -15:00
Dr Lukas Bubendorf
University of Basel, Switzerland
Immunohistochemistry: potentialities and pitfalls
fotos speakers (59).png
15:00 -15:00
Dr Colin C. Pritchard
University of Washington, Seattle, USA
Molecular pathology of prostate cancer
fotos speakers (64).png
15:20 -15:40
Q&A (Questions-and-Answers) Session

Moderator:

Dr Philippe Vielh - Medipath & American Hospital of Paris, France
JULY 9th 2022 - 15:40 - France time - Central European Summer Time (CEST)
fotos speakers (58).png
15:40 - 16:00
Dr Aurel Messas
American Hospital of Paris, France
MRI fusion for targeted diagnosis and treatment
fotos speakers (61).png
16:00 -16:20
Dr Anna Patrikidou
Gustave Roussy Cancer Institute, Villejuif, France
Medical treatment
fotos speakers (57).png
16:20 -16:40
Dr Douglas Clark
Ibex, Tel Aviv, Israel
AI in primary diagnosis of prostate biopsies: from promise to clinical reality
fotos speakers (56).png
16:40 -17:00
Dr Alexander Wyatt
University of British Columbia, Vancouver, Canada
Plasma ctDNA analysis in prostate cancer
fotos speakers (55).png
17:00 -17:20
Dr Michael Haffner
Fred Hutchinson Cancer Research Center, Seattle, USA
The role of BRAC
fotos speakers (92).png
17:20 -17:40
Q&A (Questions-and-Answers) Session

Moderator:

Dr Lukas Bubendorf - University of Basel, Switzerland